(NECN) - Investors were tough on Boston Scientific Corporation on Monday after it announced that it would temporarily halt shipments and recall inventory of several brands of implantable heart defibrillators.
It says it uncovered two production changes that were not cleared with the FDA.
The company says it will retrieve affected devices from suppliers and hospitals.
Lisa Van der Pool of the Boston Business Journal joins us with more on this.
Copyright NECNMIGR - NECN
